Experimental cancer drug trial halted after early testing
NCT ID NCT05070247
First seen Jan 24, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tested a new drug called TAK-500, alone or with pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The goal was to check safety and see if the drug could shrink tumors. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
New York University
New York, New York, 10016-4744, United States
-
Northwestern
Chicago, Illinois, 60611, United States
-
START South Texas Accelerated Research Therapeutics
San Antonio, Texas, 78229, United States
-
Sarah Cannon Cancer Institute
Nashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute
Denver, Colorado, 80218, United States
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
Univeristy of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California San Diego
La Jolla, California, 92093, United States
-
University of Colorado - Anschutz Medical Campus - PPDS
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.